Nerve growth factor, birth outcome and pre-eclampsia

International Journal of Developmental Neuroscience

Volumn 29, Issue 1, 2011, Pages 71-75

  Kilari, Anitha ^a   Mehendale, Savita ^b   Pisal, Hemlata ^a   Panchanadikar, Tushar ^b   Kale, Anvita ^a   Joshi, Sadhana ^a  

^a Bharati Vidyapeeth Deemed University   (India)

^b Bharati Vidyapeeth's Medical College   (India)

Author keywords

Low birth weight; NGF; Pre eclampsia

Indexed keywords

NERVE GROWTH FACTOR;

ADULT; ARTICLE; BIRTH WEIGHT; BLOOD PRESSURE; CONTROLLED STUDY; FEMALE; HUMAN; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MATERNAL BLOOD; NEWBORN; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

BIRTH WEIGHT; BLOOD PRESSURE; FEMALE; FETAL BLOOD; GESTATIONAL AGE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; NERVE GROWTH FACTOR; PRE-ECLAMPSIA; PREGNANCY;

EID: 78650177692     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2010.09.001     Document Type: Article

References (32)

1. Alleva E., Francia N. Psychiatric vulnerability: suggestions from animal models and role of neurotrophins. Neurosci. Biobehav. Rev. 2009, 33:525-536.
2. Cabrera-Vásquez S., Navarro-Tableros V., Sánchez-Soto C., Gutiérrez-Ospina G., Hiriart M. Remodelling sympathetic innervation in rat pancreatic islets ontogeny. BMC Dev. Biol. 2009, 9:34.
3. Calza L., Giardino L., Giuliani A., Aloe L., Levi-Montalcini R. Nerve growth factor control of neuronal expression of angiogenetic and vasoactive factors. Proc. Natl. Acad. Sci. 2001, 98:4160-4165.
4. Cannon T.D., Yolken R., Buka S., Torrey E.F. Decreased neurotrophic response to birth hypoxia in the etiology of schizophrenia. Biol. Psychiatry 2008, 64:797-802. Collaborative Study Group on the Perinatal Origins of Severe Psychiatric Disorders.
5. Cantarella G., Lempereur L., Presta M., Ribatti D., Lombardo G., Lazarovici P., Zappalà G., Pafumi C., Bernardini R. Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. FASEB J. 2002, 16:1307-1309.
6. Chaldakov G.N., Fiore M., Stankulov I.S., Hristova M., Antonelli A., Manni L., Ghenev P.I., Angelucci F., Aloe L. NGF, BDNF, leptin, and mast cells in human coronary atherosclerosis and metabolic syndrome. Arch. Physiol. Biochem. 2001, 109:357-360.
7. De Vivo A., Baviera G., Giordano D., Todarello G., Corrado F., D'anna R. Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia. Acta Obstet. Gynecol. Scand. 2008, 87:837-8342.
8. Germani E., Lesma E., Di Giulio A.M., Gorio A. Progressive and selective changes in neurotrophic factor expression and substance p axonal transport induced by perinatal diabetes: protective action of antioxidant treatment. J. Neurosci. Res. 1999, 57:521-528.
9. Haddad J., Vilge V., Juif J.G., Maitre M., Donato L., Messer J., Mark J. Beta-nerve growth factor levels in newborn cord sera. Pediatr. Res. 1994, 35:637-639.
10. Hu Y., Wang Y.D., Guo T., Wei W.N., Sun C.Y., Zhang L., Huang J. Identification of brain-derived neurotrophic factor as a novel angiogenic protein in multiple myeloma. Cancer Genet. Cytogenet. 2007, 178:1-10.
11. Inder T.E., Volpe J.J. Mechanisms of perinatal brain injury. Semin. Neonatol. 2000, 5:3-16.
12. Julio-Pieper M., Lara H.E., Bravo J.A., Romero C. Effects of nerve growth factor (NGF) on blood vessels area and expression of the angiogenic factors VEGF and TGF-beta 1 in the rat ovary. Reprod. Biol. Endocrinol. 2006, 4:57-67.
13. Kajantie E., Eriksson J.G., Osmond C., Thornburg K., Barker D.J. Pre-eclampsia is associated with increased risk of stroke in the adult offspring: the Helsinki birth cohort study. Stroke 2009, 40:1176-1180.
14. Kale A., Joshi S., Pillai A., Naphade N., Raju M., Nasrallah H., Mahadik S. Reduced cerebrospinal fluid and plasma nerve growth factor in drug-naïve psychotic patients. Schizophr. Res. 2009, 115:209-214.
15. Kawamura K., Kawamura N., Sato W., Fukuda J., Kumagai J., Tanaka T. Brain-derived neurotrophic factor promotes implantation and subsequent placental development by stimulating trophoblast cell growth and survival. Endocrinology 2009, 150:3774-3782.
16. Kulkarni A., Mehendale S., Yadav H., Kilari A., Taralekar V., Joshi S. Circulating angiogenic factors and their association with birth outcomes in pre-eclampsia. Hypertens. Res. 2010, 33:561-567.
17. Laskowska M., Laskowska K., Leszczyńska-Gorzelak B., Oleszczuk J. Are the maternal and umbilical VEGF-A and SVEGF-R1 altered in pregnancies complicated by preeclampsia with or without intrauterine foetal growth retardation? Preliminary communication. Med. Wieku. Rozwoj. 2008, 12:499-506.
18. Levine R.J., Maynard S.E., Qian C., Lim K.H., England L.J., Yu K.F., Schisterman E.F., Thadhani R., Sachs B.P., Epstein F.H., Sibai B.M., Sukhatme V.P., Karumanchi S.A. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 2004, 350:672-683.
19. Malamitsi-Puchner A., Nikolaou K.E., Economou E., Boutsikou M., Boutsikou T., Kyriakakou M., Puchner K.P., Hassiakos D. Intrauterine growth restriction and circulating neurotrophin levels at term. Early Hum. Dev. 2007, 83:465-469.
20. Myatt L., Webster Vascular biology of preeclampsia. J. Thromb. Haemost. 2009, 7:375-384.
21. Mehendale S., Kilari A., Dangat K., Taralekar V., Mahadik S., Joshi S. Fatty acids, antioxidants, and oxidative stress in pre-eclampsia. Int. J. Gynaecol. Obstet. 2008, 100:234-238.
22. Nico B., Mangieri D., Benagiano V., Crivellato E., Ribatti D. Nerve growth factor as an angiogenic factor. Microvasc. Res. 2008, 75:135-141.
23. Park M.J., Kwak H.J., Lee H.C., Yoo D.H., Park I.C., Kim M.S., Lee S.H., Rhee C.H., Hong S.I. Nerve growth factor induces endothelial cell invasion and cord formation by promoting matrix metalloproteinase-2 expression through the phosphatidylinositol 3-kinase/Akt signaling pathway and AP-2 transcription factor. J. Biol. Chem. 2007, 282:30485-30496.
24. Pucci S., Mazzarelli P., Missiroli F., Regine F., Ricci F. Neuroprotection: VEGF, IL-6, and clusterin: the dark side of the moon. Prog. Brain Res. 2008, 173:555-573.
25. Quinn M. Pre-eclampsia and partial uterine denervation. Med. Hypotheses 2005, 64:449-454.
26. Rehn A.E., Van Den Buuse M., Copolov D., Briscoe T., Lambert G., Rees S. An animal model of chronic placental insufficiency: relevance to neurodevelopmental disorders including schizophrenia. Neuroscience 2004, 129:381-391.
27. Shaarawy M., Al-Sokkary F., Sheba M., Wahba O., Kandil H.O., Abdel-Mohsen I. Angiogenin and vascular endothelial growth factor in pregnancies complicated by preeclampsia. Int. J. Gynaecol. Obstet. 2005, 88:112-117.
28. Sherer T.B., Neff P.S., Tuttle J.B. Increased nerve growth factor mRNA stability may underlie elevated nerve growth factor secretion from hypertensive vascular smooth muscle cells. Brain Res. Mol. Brain Res. 1998, 62:167-174.
29. Sizonenko S.V., Borradori-Tolsa C., Bauthay D.M., Lodygensky G., Lazeyras F., Hüppi P. Impact of intrauterine growth restriction and glucocorticoids on brain development: insights using advanced magnetic resonance imaging. Mol. Cell Endocrinol. 2006, 254-255:163-171.
30. Torasdotter M., Metsis M., Henriksson B.G., Winblad B., Mohammed A.H. Environmental enrichment results in higher levels of nerve growth factor mRNA in the rat visual cortex and hippocampus. Behav. Brain Res. 1998, 93:83-90.
31. Toti P., Ciarmela P., Florio P., Volpi N., Occhini R., Petraglia F. Human placenta and fetal membranes express nerve growth factor mRNA and protein. J. Endocrinol. Invest. 2006, 29:337-341.
32. Zettler C., Bridges D.C., Zhou X.F., Rush R.A. Detection of increased tissue concentrations of nerve growth factor with an improved extraction procedure. J. Neurosci. Res. 1996, 46:581-594.